OptimizeRx Corporation (OPRX) exhibits 67.3% gross margins and 7.3% return on invested capital within Consumer Discretionary (Business Services), balanced against a 14.9x enterprise multiple and 4.8% implied options volatility.
Sustained 67.3% gross profitability converts into 10.7% operating margin and 7.3% ROIC, outpacing sector cost of capital.
ROIC: 7.3% // GM: 67.3%YoY revenue trajectory of +18.8% paired with 10.57% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +18.8% // FCF YLD: 10.57%Altman Z-Score of 2.68 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.68 // F-SCORE: 9/9Trading at 34.4x trailing P/E (28.9x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 34.4x // EV/EBITDA: 14.9xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $9.37 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Business Services require continuous execution to defend 4.7% net margins.
NET MARGIN: 4.7% // D/E: 0.17x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for OPRX & activate live FRED threshold breach alerts.